Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Acura Pharmaceuticals Accounts Receivable (Quarterly): 0.54M for Sept. 30, 2021
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
December 31, 2021 | 0.158M |
September 30, 2021 | 0.54M |
June 30, 2021 | 1.114M |
March 31, 2021 | 0.934M |
December 31, 2020 | 0.627M |
September 30, 2020 | 0.921M |
June 30, 2020 | 0.779M |
March 31, 2020 | 0.035M |
December 31, 2019 | 0.16M |
September 30, 2019 | 0.181M |
June 30, 2019 | 0.044M |
March 31, 2019 | 0.056M |
December 31, 2018 | 0.137M |
September 30, 2018 | 0.108M |
June 30, 2018 | 0.094M |
March 31, 2018 | |
December 31, 2017 | 0.071M |
September 30, 2017 | 0.065M |
June 30, 2017 | 0.051M |
March 31, 2017 | 0.094M |
December 31, 2016 | 0.152M |
September 30, 2016 | 0.169M |
June 30, 2016 | 0.211M |
March 31, 2016 | 0.14M |
December 31, 2015 | 0.083M |
Date | Value |
---|---|
September 30, 2015 | 0.167M |
June 30, 2015 | 0.109M |
March 31, 2015 | 0.087M |
December 31, 2014 | 0.076M |
September 30, 2014 | 0.132M |
June 30, 2014 | 0.086M |
March 31, 2014 | 0.105M |
December 31, 2013 | 0.194M |
September 30, 2013 | 0.055M |
June 30, 2013 | 0.008M |
March 31, 2013 | 0.018M |
December 31, 2012 | 0.005M |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.035M
Minimum
Mar 2020
1.114M
Maximum
Jun 2021
0.4994M
Average
0.54M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.759M |
Palatin Technologies Inc | 2.346M |
iBio Inc | -- |
Theriva Biologics Inc | -- |
Oragenics Inc | -- |